Discontinued — last reported Q4 '25
West Pharmaceutical Services Change in Other Current Assets remained flat by 0.0% to -$2.43M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 267.2%, from $1.45M to -$2.43M. Over 4 years (FY 2021 to FY 2025), Change in Other Current Assets shows a downward trend with a 7.4% CAGR.
Large fluctuations may indicate changes in tax positions or prepayments for future services.
This captures the net change in short-term assets that are not classified as cash, receivables, or inventory. These item...
Generally minor for most firms; peers may show variance based on tax timing or specific short-term investment strategies.
change_in_other_current_assets| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $7.30M | -$18.50M | $21.30M | $5.80M | -$9.70M |
| YoY Change | — | -353.4% | +215.1% | -72.8% | -267.2% |